Innoviva, Inc. (INVA)
NASDAQ·Healthcare·Biotechnology
$20.75
-0.05%
Mkt Cap $1.60B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$37.00
Range $32.00 – $42.00
Implied Upside
+78.4%
Consensus $37.00 vs current $20.75
NASDAQ·Healthcare·Biotechnology
$20.75
-0.05%
Mkt Cap $1.60B
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$37.00
Range $32.00 – $42.00
+78.4%
Consensus $37.00 vs current $20.75